DAX22.426 +0,7%ESt505.162 -0,2%Top 10 Crypto12,50 +3,1%Dow40.588 +0,9%Nas17.480 +0,7%Bitcoin83.832 +0,6%Euro1,1381 -0,4%Öl64,16 -2,3%Gold3.324 -0,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Deutsche Bank 514000 Lufthansa 823212 Tesla A1CX3T RENK RENK73 Mercedes-Benz Group (ex Daimler) 710000 Porsche PAG911 Siemens Energy ENER6Y BASF BASF11 BYD A0M4W9 Amazon 906866 Plug Power A1JA81 Allianz 840400 Volkswagen (VW) vz. 766403
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX letztlich höher -- Dow stärker -- PayPal enttäuscht beim Umsatz -- Deutsche Bank mit mehr Umsatz -- Porsche senkt Prognose -- Palantir, Rheinmetall, Plug Power, Lufthansa, BASF im Fokus
Top News
Konkurrenz für Musk: Erste Amazon-Satelliten im All - Aktie verliert Konkurrenz für Musk: Erste Amazon-Satelliten im All - Aktie verliert
Microsoft-Aktie in Grün: ChatGPT künftig mit Kaufberatung Microsoft-Aktie in Grün: ChatGPT künftig mit Kaufberatung
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Europäische Aktien bieten Grund für Optimismus. Ihre Aussichten könnten langfristig besser sein als für die erfolgsverwöhnten US-Titel. DWS informiert

Eli Lilly Aktie

NeuKaufenVerkaufen
Eli Lilly Aktien-Sparplan
782,30 EUR +20,80 EUR +2,73 %
FSE
890,20 USD +13,01 USD +1,48 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.730,04 Mrd. EUR

KGV65,91Div. Rendite0,67%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN858560

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS5324571083

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolLLY

Eli Lilly Aktien News

DatumMeistgelesen
PR NewswireLilly Declares Third-Quarter 2023 Dividend
PR NewswireLilly's SURMOUNT-2 results published in The Lancet show tirzepatide achieved a mean weight reduction of 15.7% at the highest dose (15 mg) in adults with obesity or overweight and type 2 diabetes
PR NewswireLilly's phase 2 results published in the New England Journal of Medicine show orforglipron, a once-daily oral nonpeptide GLP-1 receptor agonist, achieved up to 14.7% mean weight reduction at 36 we...
PR NewswireUS FDA approves Jardiance® (empagliflozin) for the treatment of type 2 diabetes in children 10 years and older
PR NewswireLilly to present new research in the treatment of diabetes and obesity at the American Diabetes Association's® 83rd Scientific Sessions
PR NewswireLilly Teams up with the American Diabetes Association and Adam Duvall to Launch "Tap the Cap"
PR NewswireLilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
PR NewswireFirst-Of-Its-Kind Head-to-Head Clinical Trial Reaffirms the Efficacy of Emgality in Episodic Migraine Prevention
PR NewswireLilly Highlights Verzenio® (abemaciclib) and Jaypirca™ (pirtobrutinib) Data at 2023 ASCO® Annual Meeting
PR NewswireLilly to Participate in Goldman Sachs Global Healthcare Conference
PR NewswireLilly ESG Report Highlights Progress Towards Sustainability Goals
PR NewswireLilly's peresolimab Phase 2a rheumatoid arthritis trial published in The New England Journal of Medicine
PR NewswireLoxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting
PR NewswireLilly's Social Impact Venture Capital Portfolio Poised to Grow to $300 Million with New $50 Million Allocation
PR NewswireLilly Discloses First-in-Class, Interim Phase 2 Data in Pediatric Patients and New Analysis from Phase 3 Program in Adult Patients for Mirikizumab in Ulcerative Colitis
PR NewswireLilly to Participate in Bank of America Securities 2023 Healthcare Conference
PR NewswireLilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease
PR NewswireLilly Provides $500,000 in Grants to Support Equitable Access to Education for Dreamers in Indiana
MyDividendsEli Lilly meldet Dividende für das zweite Quartal
PR NewswireLilly Declares Second-Quarter 2023 Dividend
PR NewswireUp to 73% of Atopic Dermatitis Patients Taking Lilly's Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis
PR NewswireLilly Reports First-Quarter 2023 Financial Results, Highlights Continued Core Business Growth and Pipeline Momentum
PR NewswireLilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2
PR NewswireLilly to Divest BAQSIMI to Amphastar
PR NewswireLilly to Make Record-Breaking Investment in Indiana Manufacturing Facilities
PR NewswireU.S. Food and Drug Administration Issues Complete Response Letter for Mirikizumab
PR NewswireLilly Confirms Date and Conference Call for First-Quarter 2023 Financial Results Announcement
PR NewswireLilly Announces Details of Presentations at 2023 American Association for Cancer Research (AACR) Annual Meeting
PR NewswireLilly Provides Update on A4 Study of Solanezumab for Preclinical Alzheimer's Disease
PR NewswireUS FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes
PR NewswireIntensive education at clinics about multidisciplinary care improved likelihood that adults with type 2 diabetes and cardiovascular disease were receiving guideline-directed medicines, according t...
PR NewswireU.S. FDA Broadens Indication for Verzenio® (abemaciclib) in HR+, HER2-, Node-Positive, High Risk Early Breast Cancer
PR NewswireLilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month
PR NewswireLilly to Participate in Cowen's 43rd Annual Health Care Conference
PR NewswireLilly and IABL Collaborate to Ensure Patient Access to High-Quality Affordable Insulin in Bangladesh
PR NewswireLilly to Participate in SVB Securities Global Biopharma Conference
PR NewswireLilly to Participate in Guggenheim Oncology Conference
PR NewswireU.S. FDA Approves Jaypirca™ (pirtobrutinib), the First and Only Non-Covalent (Reversible) BTK Inhibitor, for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma After at Least Two Line...
PR NewswireLilly Supports Direct Relief's Efforts to Expand Access to Medicines by Improving Cold Chain Capacity
PR NewswireLilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle Park
Wer­bung

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.